Assessing the Predictive Value of JAK2 V617F Allele Burden in Non-CML Classical Subtypes of Myeloproliferative Neoplasms

被引：0
|
作者：
Gober-Wilcox, Julie [1 ]
Vennapusa, Bharathi [1 ]
Pierce, Joseph [2 ]
Vasef, Mohammad A. [1 ,2 ]
机构：
[1] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA
[2] TriCore Reference Lab, Albuquerque, NM USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2009年 / 132卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
28
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [41] TELOMERE LOSS IN PH - NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS: THE ROLE OF JAK2 V617F MUTATION ALLELE BURDEN AND THE INFLUENCE OF THE HISTORY OF THE ILLNESS
    Ruella, M.
    Salmoiraghi, S.
    Risso, A.
    Carobbio, A.
    Sivera, P.
    Mezzabotta, M.
    Ricca, I.
    Barbui, T.
    Tarella, C.
    Rambaldi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 164 - 164
  • [42] Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype
    Cross, Nicholas C. P.
    Jones, Amy V.
    Silver, Richard T.
    Oscier, David
    Metzgeroth, Georgia
    Wang, Y. Lynn
    Collins, Andrew
    Reiter, Andreas
    Grand, Francis
    Chase, Andrew
    BLOOD, 2008, 112 (11) : 71 - 71
  • [43] No evidence for amplification of V617F JAK2 in myeloproliferative disorders
    A V Jones
    D J Bunyan
    N C P Cross
    Leukemia, 2007, 21 : 2561 - 2563
  • [44] JAK2 V617F: implications for thrombosis in myeloproliferative diseases
    Hexner, Elizabeth O.
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (05) : 450 - 454
  • [45] JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms
    J Wang
    Z Xu
    L Liu
    R P Gale
    N C P Cross
    A V Jones
    T Qin
    X Ai
    J Xu
    T Zhang
    X Sun
    Q Li
    P Zhang
    Y Zhang
    Z Xiao
    Leukemia, 2013, 27 : 1763 - 1767
  • [46] JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms
    Wang, J.
    Xu, Z.
    Liu, L.
    Gale, R. P.
    Cross, N. C. P.
    Jones, A. V.
    Qin, T.
    Ai, X.
    Xu, J.
    Zhang, T.
    Sun, X.
    Li, Q.
    Zhang, P.
    Zhang, Y.
    Xiao, Z.
    LEUKEMIA, 2013, 27 (08) : 1763 - 1767
  • [47] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Tanja Belcic Mikic
    Tadej Pajic
    Matjaz Sever
    Scientific Reports, 9
  • [48] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
    Gango, Ambrus
    Mozes, Reka
    Boha, Zsofia
    Kajtar, Bela
    Timar, Botond
    Kiraly, Peter Attila
    Kiss, Richard
    Fesus, Viktoria
    Nagy, Noemi
    Demeter, Judit
    Korosmezey, Gabor
    Borbenyi, Zita
    Marton, Imelda
    Szoke, Anita
    Masszi, Tamas
    Farkas, Peter
    Varkonyi, Judit
    Plander, Mark
    Posfai, Eva
    Egyed, Miklos
    Pal, Katalin
    Radvanyi, Gaspar
    Hamed, Aryan
    Csomor, Judit
    Matolcsy, Andras
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
  • [49] JAK2 V617F mutation in Iranian patients with myeloproliferative neoplasms: clinical and laboratory findings
    Poopak, Behzad
    Farshdousti Hagh, Majid
    Saki, Najmaldin
    Elahi, Fazel
    Rezvani, Hamid
    Khosravipour, Gelareh
    Jahangirpour, Mohammad Ali
    Bolouri, Shirin
    Golkar, Tolou
    Falah, Parviz
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2013, 43 (03) : 347 - 353
  • [50] JAK2 V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms
    Oyama, Naoki
    Iwamoto, Takanori
    Doyu, Keito
    Miyazato, Saki
    Okazaki, Tomoko
    Yamada, Seiko
    Kondo, Toshinori
    Wada, Hideho
    Yagita, Yoshiki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (12) : 1917 - 1926
12345